Ra Medical Systems, Inc. RMED NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score

31/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ra Medical Systems, Inc. (RMED) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 30/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

31/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✗

FUTURE

20/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

✗

HEALTH

17/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

✓

GROWTH

90/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — RMED

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio783.74

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-15.90

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-433.96	$5.98M	$-4.2M	-70.3%
2017	$-1,834.66	$5.87M	$-17.77M	-302.6%
2018	$-4,175.51	$6.26M	$-30.83M	-492.8%
2019	$-5,416.22	$7.2M	$-56.96M	-791.2%
2020	$-1,060.77	$4.41M	$-36.05M	-818.3%
2021	$-269.91	$22K	$-27.26M	-123913.6%
2022	$-25.98	$14K	$-26.87M	-191892.9%
2024	$-6.68	$420K	$-21.8M	-5190.7%
2025	$-15.90	$819K	$-17.18M	-2098%